Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.
Kilian A, Chock YP, Huang IJ, Graef ER, Upton LA, Khilnani A, Krupnikova SDS, Almaghlouth I, Cappelli LC, Fernandez-Ruiz R, Frankel BA, Frankovich J, Harrison C, Kumar B, Monga K, Vega JAR, Singh N, Sparks JA, Sullo E, Young KJ, Duarte-Garcia A, Putman M, Johnson S, Grainger R, Wallace ZS, Liew JW, Jayatilleke A. Kilian A, et al. Semin Arthritis Rheum. 2020 Oct;50(5):1191-1201. doi: 10.1016/j.semarthrit.2020.07.007. Epub 2020 Jul 22. Semin Arthritis Rheum. 2020. PMID: 32931985 Free PMC article. Review.
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E, Ugarte-Gil MF, Webb K, Grainger R; COVID-19 Global Rheumatology Alliance. Kim AHJ, et al. Ann Intern Med. 2020 Jun 16;172(12):819-821. doi: 10.7326/M20-1223. Epub 2020 Mar 30. Ann Intern Med. 2020. PMID: 32227189 Free PMC article.
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.
Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA; COVID-19 Global Rheumatology Alliance. Graef ER, et al. Ann Rheum Dis. 2020 Jun;79(6):734-736. doi: 10.1136/annrheumdis-2020-217480. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295786 Free PMC article. Review. No abstract available.
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Sattui SE, et al. Expert Rev Clin Immunol. 2020 Jul;16(7):659-666. doi: 10.1080/1744666X.2020.1792778. Epub 2020 Aug 11. Expert Rev Clin Immunol. 2020. PMID: 32620062 Free PMC article. Review.
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A; COVID-19 Global Rheumatology Alliance. Putman M, et al. Arthritis Rheumatol. 2021 Jan;73(1):36-47. doi: 10.1002/art.41469. Epub 2020 Nov 19. Arthritis Rheumatol. 2021. PMID: 32741139 Free PMC article.
The protective effect of rheumatic disease agents in COVID-19.
Valenzuela-Almada MO, Putman MS, Duarte-García A. Valenzuela-Almada MO, et al. Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101659. doi: 10.1016/j.berh.2021.101659. Epub 2021 Jan 13. Best Pract Res Clin Rheumatol. 2021. PMID: 33526326 Free PMC article. Review.
Reply.
Putman M, Sattui SE, Sparks JA, Liew JW, Grainger R, Duarte-García A. Putman M, et al. Arthritis Rheumatol. 2021 Sep;73(9):1767-1768. doi: 10.1002/art.41745. Epub 2021 Aug 3. Arthritis Rheumatol. 2021. PMID: 33779057 Free PMC article. No abstract available.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Yazdany J; COVID-19 Global Rheumatology Alliance. Sparks JA, et al. Ann Rheum Dis. 2021 Sep;80(9):1137-1146. doi: 10.1136/annrheumdis-2021-220418. Epub 2021 May 28. Ann Rheum Dis. 2021. PMID: 34049860 Free PMC article.
100 results